About this trial
This study aims to investigate the impact of varying degrees of neuromuscular blockade on postoperative pain in pediatric patients aged over 2 months to under 7 years undergoing laparoscopic surgery under general anesthesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pediatric patients aged over 2 months to under 7 years scheduled for laparoscopic surgery under general anesthesia.
American Society of Anesthesiologists (ASA) Physical Status Classification I, II, or III.
Disqualifiers
Patients undergoing emergency surgery.
Patients with chronic pain or currently taking analgesics for chronic pain.
Known hypersensitivity to general anesthetic agents or analgesics.
Patients with underlying cardiovascular disease.
Trial design
Parallel
Treatments tested in this trial
rocuronium 0.2 mg/kg/hr continuous infusion
DrugTo maintain Train-of-four count 1 to 3 during surgery: Administration of continuous infusion of rocuronium at a rate of 0.2 mg/kg/hr to achieve and sustain moderate neuromuscular blockade.
rocuronium 0.6 mg/kg/hr continuous infusion
DrugTo maintain Train-of-four count 0 during surgery: Administration of continuous infusion of rocuronium at a rate of 0.6 mg/kg/hr to achieve and sustain deep neuromuscular blockade.
Treatment groups
Trial outcomes
Primary outcomes
ANIm (Analgesia Nociception Index) Value
Secondary outcomes
FLACC Pain Scale
Pediatric Anesthesia Emergence Delirium Scale
Time to Extubation
Recovery Room Length of Stay
Sponsors and contacts
Click on the lead sponsor to view all of their trials.